Risk factors for peri-megaprosthetic joint infections in tumor surgery: A systematic review

Vasileios Karampikas1, Panayiotis Gavriil1, Stavros Goumenos1

  • 1First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, 41 Ventouri Street, 15562, Holargos, Athens, Greece.

SICOT-J
|May 31, 2024
PubMed
Abstract

Insights

Identifying risk factors for peri-megaprosthetic joint infections (PJI) after limb salvage surgery is crucial for patient outcomes. This review summarizes key PJI risks in tumor surgery with megaprosthetic reconstruction.

Area of Science:

  • Orthopedic Surgery
  • Oncology
  • Infectious Diseases

Background:

  • Peri-megaprosthetic joint infections (PJI) are significant complications following tumor surgery with megaprosthetic reconstruction.
  • PJI severely impacts patient outcomes and threatens the success of limb salvage procedures.

Purpose of the Study:

  • To identify and summarize risk factors for PJI in tumor surgery involving megaprosthetic reconstruction.
  • To determine the overall incidence of PJI in patients undergoing limb salvage surgery for bone tumors.

Main Methods:

  • A systematic literature review was conducted to analyze the incidence of PJI in tumor prostheses after limb salvage surgery.
  • Eligible studies documented PJI incidence and explored associated risk factors in tumor patients.

Main Results:

  • Fifteen studies were included in the comprehensive analysis.
  • Significant risk factors for PJI were identified, including implant coating type, surgical site characteristics, patient demographics, and procedural factors.

Conclusions:

  • Management of tumor patients undergoing limb salvage surgery requires individualized risk assessment.
  • Tailored preventive strategies are essential to mitigate the risk of PJI in these complex cases.